Matrix metalloproteinase 11 (MMP11 or stromelysin-3) has recently been reported to play a crucial role in the development and progression of multiple malignancies. The aim of this study was to investigate the function of MMP11 expression in human gastric adenocarcinoma (GAC). Using immunohistochemistry assay, we studied the expression level of MMP11 in GAC and adjacent non-cancerous tissues (ANCT). The association between MMP11 expression and tumor size and pathological grade, as well as metastatic potential was analyzed. Through small hairpin RNA (shRNA)-mediated MMP11 knockdown in SGC-7901 GAC cells, we observed the changes of the biological behaviors of GAC cells. Our results indicated that the rate of positive expression of MMP11 was higher in GAC tissues than in ANCT (55.0% vs 30.0%, P=0.025). MMP11 expression had no association with the factors of age or gender of the GAC patients, or the size, pathological staging and lymph node metastases of the tumors (each P>0.05). Furthermore, MMP11 knockdown inhibited the proliferative activities and invasive potential of SGC-7901 GAC cells with decreased expression of IGF-1, PCNA and VEGF. Taken together, our findings demonstrated that MMP11 expression was increased in GAC tissues, but did not correlate with the clinicopathologic features. Knockdown of MMP11 expression could inhibit the proliferation and invasion of GAC cells probably through down-regulation of the IGF-1 signaling pathway, suggesting that MMP11 might be a potential therapeutic target for the treatment of gastric cancer.
Solov'evaNI. Matrix metalloproteinases and their biological functions. Bioorg Khim1998; 24:245–5.
4.
MotrescuERBlaiseSEtiqueNMessaddeqNChenardMPStollITomasettoCRioMC. Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene2008; 27:6347–55.
5.
NakopoulouLPanayotopoulouEGGiannopoulouIAlexandrouPKatsarouSAthanassiadouPKeramopoulosA. Stromelysin-3 protein expression in invasive breast cancer: Relation to proliferation, cell survival and patients' outcome. Mod Pathol2002; 15:1154–61.
6.
SelveySHauptLMThompsonEWMatthaeiKIIrvingMGGriffithsLR. Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines. BMC Cancer2004; 4:40.
7.
TakeuchiTAdachiYNagayamaTFurihataM. Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance. Virchows Arch2011; 459:291–7.
8.
Vazquez-OrtizGPina-SanchezPVazquezKDuenasATajaLMendozaPGarciaJASalcedoM. Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer2005; 5:68.
9.
ValdiviaAPeraltaRMatute-GonzálezM. Co-expression of metalloproteinases 11 and 12 in cervical scrapes cells from cervical precursor lesions. Int J Clin Exp Pathol2011; 4:674–82.
10.
YangYHDengHLiWM. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling. Clin Cancer Res2008; 14:74–81.
11.
ChengCWYuJCWangHW. The clinical implications of MMP-11 and CK-20 expression in human breast cancer. Clin Chim Acta2010; 411:234–41.
12.
KwonYJHurstDRStegADYuanKVaidyaKSWelchDRFrostAR. Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines. Clin Exp Metastasis2011; 28:437–49.
13.
MotrescuERRioMC. Cancer cells, adipocytes and matrix metalloproteinase 11: A vicious tumor progression cycle. Biol Chem2008; 389:1037–41.
14.
StojicJHagemannCHaasS. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res2008; 60:40–9.
15.
BrasseDMathelinCLerouxKChenardMPBlaiseSStollITomasettoCRioMC. Matrix metalloproteinase 11/stromelysin-3 exerts both activator and repressor functions during the hematogenous metastatic process in mice. Int J Cancer2010; 127:1347–55.
16.
Wadowska-JaszczyńskaKJachRStangel-WócikiewiczK. Results in treatment of early breast cancers and the level of selected metalloproteinases. Neuro Endocrinol Lett2011; 32:821–30.
17.
WeiLShiYB. Matrix metalloproteinase stromelysin-3 in development and pathogenesis. Histol Histopathol2005; 20:177–85.
18.
SharmaRChattopadhyayTKMathurMRalhanR. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Oncology2004; 67:300–9.
19.
SkoglundJEmterlingAArbmanGAnglardPSunXF. Clinicopathological significance of stromelysin-3 expression in colorectal cancer. Oncology2004; 67:67–72.
20.
AsanoTTadaMChengS. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma. J Surg Res2008; 146:32–42.
21.
PeruzziDMoriFConfortiALazzaroDDe RinaldisECilibertoGLa MonicaNAurisicchioL. MMP11: A novel target antigen for cancer immunotherapy. Clin Cancer Res2009; 15:4104–13.
22.
ItoYYoshidaHKakudoKNakamuraYKumaKMiyauchiA. Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma. Pathology2006; 38:421–5.
23.
YanDDaiHLiuJW. Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma. BMC Cancer2011; 11:151.
24.
WuEMariBPWangFAndersonICSundayMEShippMA. Stromelysin-3 suppresses tumor cell apoptosis in a murine model. J Cell Biochem2001; 82:549–55.
25.
JiaLWangSCaoJZhouHWeiWZhangJ. siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic capability of murine hepatocarcinoma cell Hca-F to lymph nodes. Int J Biochem Cell Biol2007; 39:2049–62.
26.
SiragamVRutnamZJYangW. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget2012; 3:1370–85.
27.
BiQTangSXiaL. Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One2012; 7:e40169.
28.
HanHBGuJZuoHJ. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. J Pathol2012; 226:544–55.
29.
DengHGuoRFLiWMZhaoMLuYY. Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells. Biochem Biophys Res Commun2005; 326:274–81.
30.
ZhaoZSChuYQYeZYWangYYTaoHQ. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol2010; 41:686–96.
31.
OubanAMuracaPYeatmanTCoppolaD. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. Hum Pathol2003; 34:803–8.
32.
KaltsasGACunninghamJLFalkmerSEGrimeliusLTsolakisAV. Expression of connective tissue growth factor and IGF1 in normal and neoplastic gastrointestinal neuroendocrine cells and their clinico-pathological significance. Endocr Relat Cancer2010; 18:61–71.
33.
ReissKPorcuPSellCPietrzkowskiZBasergaR. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells. Oncogene1992; 7:2243–8.
34.
ZatelliMCMinoiaMMartiniC. Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids. Endocr Relat Cancer2010; 17:719–29.
35.
KasperGReuleMTschirschmannM. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: Involvement of the IGF-1 signalling pathway. BMC Cancer2007; 7:12.
